Literature DB >> 10982300

Observer reliability in assessment of mitotic activity and MIB-1-determined proliferation rate in pediatric sarcomas.

W M Molenaar1, B E Plaat, E R Berends, G J te Meerman.   

Abstract

In hematoxylin-eosin-stained sections of 20 pediatric sarcomas the mitotic index was assessed by four experienced pathologists and four less-experienced observers without prior instructions. In adjacent sections immunolabeled for MIB-1, the proliferation index was assessed as the estimated percentage of labeled cells in the tumor cell population. ANOVA revealed that the variation between tumors explained 77% of the variation in mitotic indices in the group of experienced observers compared with 49% in the less experienced group. The variation between tumors explained 64% of the variation in proliferation indices in the experienced group and 71% in the less experienced group. The proliferation indices showed less variation between observers than the mitotic indices. No correlation was found between mitotic and proliferation indices. The results suggest that training is an important factor in the reliability of mitotic counting. The use of proliferation markers has a higher reproducibility, especially in less-experienced observers. However, for clinical use it has the disadvantage of being the more expensive, more time-consuming technique; moreover, the biological significance of proliferation has not been established and may differ from that of mitotic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982300     DOI: 10.1053/adpa.2000.8126

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

1.  Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Authors:  Arnaud Uguen; Gwenaël Conq; Laurent Doucet; Matthieu Talagas; Sebastian Costa; Marc De Braekeleer; Pascale Marcorelles
Journal:  Virchows Arch       Date:  2015-04-01       Impact factor: 4.064

2.  Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese.

Authors:  Tsung-Hui Hu; Seng-Kee Chuah; Jui-Wei Lin; Yi-Chun Chiu; Chi-Sin Changchien; Chih-Chi Wang; Yaw-Sen Chen; Li-Na Yi; King-Wah Chiu; Chuan-Mo Lee
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

3.  Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index.

Authors:  C Bossard; A Jarry; C Colombeix; K Bach-Ngohou; A Moreau; D Loussouarn; J-F Mosnier; C L Laboisse
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

4.  How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists.

Authors:  Zsuzsanna Varga; Joachim Diebold; Corina Dommann-Scherrer; Harald Frick; Daniela Kaup; Aurelia Noske; Ellen Obermann; Christian Ohlschlegel; Barbara Padberg; Christiane Rakozy; Sara Sancho Oliver; Sylviane Schobinger-Clement; Heide Schreiber-Facklam; Gad Singer; Coya Tapia; Urs Wagner; Mauro G Mastropasqua; Giuseppe Viale; Hans-Anton Lehr
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.

Authors:  Hao Wang; Ping Chen; Xin-Xin Liu; Wei Zhao; Lei Shi; Xue-Wen Gu; Chang-Ren Zhu; Hai-Hang Zhu; Liang Zong
Journal:  World J Surg Oncol       Date:  2014-04-09       Impact factor: 2.754

6.  Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.

Authors:  Lik Hang Lee; Hua Yang; Gilbert Bigras
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.